Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Metastatic Hormone-sensitive Prostate Cancer
View Full LandscapeTarget Indication
Metastatic Hormone-sensitive Prostate Cancer
Clinical Trial
NCT06991556Last updated: 8/16/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Multiple Sclerosis
Solid Tumors
Influenza
Chronic Obstructive Pulmonary Disease
Swine-Origin Influenza A H1N1 Virus